nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase II trial of CI-958 in patients with hormone-refractory prostate cancer
|
Woolley, Paul V. |
|
1999 |
44 |
6 |
p. 511-517 |
artikel |
2 |
A phase II trial of DA-125, a novel anthracycline, in advanced non-small-cell lung cancer
|
Kang, Y.-K. |
|
1999 |
44 |
6 |
p. 518-521 |
artikel |
3 |
Apoptotic cell death induced by baccatin III, a precursor of paclitaxel, may occur without G2/M arrest
|
Miller III, Merrill C. |
|
1999 |
44 |
6 |
p. 444-452 |
artikel |
4 |
Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients
|
Cassidy, Jim |
|
1999 |
44 |
6 |
p. 453-460 |
artikel |
5 |
Difluoromethylornithine in combination with tamoxifen in female rats: 13-week oral toxicity study
|
Brown, Alan P. |
|
1999 |
44 |
6 |
p. 475-483 |
artikel |
6 |
Erucylphosphocholine: pharmacokinetics, biodistribution and CNS-accumulation in the rat after intravenous administration
|
Erdlenbruch, Bernhard |
|
1999 |
44 |
6 |
p. 484-490 |
artikel |
7 |
Hepatic arterial infusion chemotherapy for unresectable confined liver metastases: prediction of systemic toxicity with the application of a scintigraphic and pharmacokinetic approach
|
Pelosi, Ettore |
|
1999 |
44 |
6 |
p. 505-510 |
artikel |
8 |
The pharmacokinetics of epirubicin and docetaxel in combination in rats
|
Sandström, Marie |
|
1999 |
44 |
6 |
p. 469-474 |
artikel |
9 |
The plasma pharmacokinetics and cerebrospinal fluid penetration of the thymidylate synthase inhibitor raltitrexed (TomudexTM) in a nonhuman primate model
|
Widemann, Brigitte C. |
|
1999 |
44 |
6 |
p. 439-443 |
artikel |
10 |
Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide – a Southwest Oncology Group clinical and pharmacokinetic study
|
Grunberg, Steven M. |
|
1999 |
44 |
6 |
p. 461-468 |
artikel |
11 |
Wortmannin inhibits the growth of mammary tumors despite the existence of a novel wortmannin-insensitive phosphatidylinositol-3-kinase
|
Lemke, Leslie E. |
|
1999 |
44 |
6 |
p. 491-497 |
artikel |
12 |
WR-2721 (amifostine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a Pediatric Oncology Group study
|
Souid, Abdul-Kader |
|
1999 |
44 |
6 |
p. 498-504 |
artikel |